Deal comes as EZZ plans to enter US market in H2 FY25, ensuring enhanced production efficiencies and supply chain logistics GLSP will manufacture EZZ-branded dietary supplements in compliance with ...
EZZ Life Science reports record revenue from operating expenses of $30.3 million during H2 FY25 as progress made on US expansion. Don't miss out on the headlines from Stockhead. Followed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback